Ovarian Cancer tests helps your doctor determine if you are eligible for PARP inhibitors
Optimise your ovarian cancer treatment
myChoice CDx for PARP Inhibitors
Myriad Genetics is a leading molecular diagnostic company based in USA. Available in India, learn if you can take PARP inhibitors to treat your Ovarian Cancer with companion diagnostic test myChoice CDx.
Positive Bioscience is the exclusive partner for Myriad Genetics and only authorised provider of myChoice Cdx in India.
Our brochure explains in detail the benefits of the test as well as what is included.
A test to help get the right treatment, to the right patient with ovarian cancer, at the right time.
Biomarkers for Homologous Recombination Deficiency (HRD)
Ovarian Cancer Test = myChoice CDx
A test to help get the right treatment, to the right patient with ovarian cancer, at the right time. DNA damage in ovarian cancer includes BRCA mutated causes.
Know if you are eligible for PARP Inhibitors
With over 20 years of experience, Myriad Genetics is a pioneer of cancer risk assessment. This is not a blood test. The test will help you determine if your doctor can prescribe you PARP inhibitors. Talk to your doctor and improve your quality of life.